Many studies demonstrated that tumors characterized by increased intra-tumoral infiltration of activated CD8+ and NK cells (termed as “inflamed” tumor microenvironment), are more susceptible to ICI-based immunotherapy [102,103]. The gene discussed is CD8A; the disease is neoplasm.